Literature DB >> 18708323

Sharing the burden: antigen transport and firebreaks in immune responses.

Andreas Handel1, Andrew Yates, Sergei S Pilyugin, Rustom Antia.   

Abstract

Communication between cells is crucial for immune responses. An important means of communication during viral infections is the presentation of viral antigen on the surface of an infected cell. Recently, it has been shown that antigen can be shared between infected and uninfected cells through gap junctions, connexin-based channels, that allow the transport of small molecules. The uninfected cell receiving antigen can present it on its surface. Cells presenting viral antigen are detected and killed by cytotoxic T lymphocytes. The killing of uninfected cells can lead to increased immunopathology. However, the immune response might also profit from killing those uninfected bystander cells. One benefit might be the removal of future 'virus factories'. Another benefit might be through the creation of 'firebreaks', areas void of target cells, which increase the diffusion time of free virions, making their clearance more likely. Here, we use theoretical models and simulations to explore how the mechanism of gap junction-mediated antigen transport (GMAT) affects the dynamics of the virus and immune response. We show that under the assumption of a well-mixed system, GMAT leads to increased immunopathology, which always outweighs the benefit of reduced virus production due to the removal of future virus factories. By contrast, a spatially explicit model leads to quite different results. Here we find that the firebreak mechanism reduces both viral load and immunopathology. Our study thus shows the potential benefits of GMAT and illustrates how spatial effects may be crucial for the quantitative understanding of infection dynamics and immune responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18708323      PMCID: PMC2659692          DOI: 10.1098/rsif.2008.0258

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.118


  43 in total

1.  TNF-alpha plus IFN-gamma induce connexin43 expression and formation of gap junctions between human monocytes/macrophages that enhance physiological responses.

Authors:  Eliseo A Eugenín; María C Brañes; Joan W Berman; Juan C Sáez
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

Review 2.  Plasma membrane channels formed by connexins: their regulation and functions.

Authors:  Juan C Saez; Viviana M Berthoud; Maria C Branes; Agustin D Martinez; Eric C Beyer
Journal:  Physiol Rev       Date:  2003-10       Impact factor: 37.312

Review 3.  Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens.

Authors:  William R Heath; Gabrielle T Belz; Georg M N Behrens; Christopher M Smith; Simon P Forehan; Ian A Parish; Gayle M Davey; Nicholas S Wilson; Francis R Carbone; Jose A Villadangos
Journal:  Immunol Rev       Date:  2004-06       Impact factor: 12.988

4.  Differential regulation of gap junctions by proinflammatory mediators in vitro.

Authors:  J Hu; I A Cotgreave
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

Review 5.  Emerging issues of connexin channels: biophysics fills the gap.

Authors:  A L Harris
Journal:  Q Rev Biophys       Date:  2001-08       Impact factor: 5.318

6.  Influenza A virus-induced apoptosis in bronchiolar epithelial (NCI-H292) cells limits pro-inflammatory cytokine release.

Authors:  Edward W A Brydon; Harry Smith; Clive Sweet
Journal:  J Gen Virol       Date:  2003-09       Impact factor: 3.891

7.  Differential induction of cytotoxicity and apoptosis by influenza virus strains of differing virulence.

Authors:  G E Price; H Smith; C Sweet
Journal:  J Gen Virol       Date:  1997-11       Impact factor: 3.891

Review 8.  Gap junctions and connexin-mediated communication in the immune system.

Authors:  Ernesto Oviedo-Orta; W Howard Evans
Journal:  Biochim Biophys Acta       Date:  2004-03-23

9.  Gap-junction communication pathways in germinal center reactions.

Authors:  T Krenacs; M Rosendaal
Journal:  Dev Immunol       Date:  1998

10.  Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread.

Authors:  Andreas Handel; Ira M Longini; Rustom Antia
Journal:  PLoS Comput Biol       Date:  2007-12       Impact factor: 4.475

View more
  6 in total

1.  Quantifying the early immune response and adaptive immune response kinetics in mice infected with influenza A virus.

Authors:  Hongyu Miao; Joseph A Hollenbaugh; Martin S Zand; Jeanne Holden-Wiltse; Tim R Mosmann; Alan S Perelson; Hulin Wu; David J Topham
Journal:  J Virol       Date:  2010-04-21       Impact factor: 5.103

2.  How sticky should a virus be? The impact of virus binding and release on transmission fitness using influenza as an example.

Authors:  Andreas Handel; Victoria Akin; Sergei S Pilyugin; Veronika Zarnitsyna; Rustom Antia
Journal:  J R Soc Interface       Date:  2014-01-15       Impact factor: 4.118

3.  Virus replication strategies and the critical CTL numbers required for the control of infection.

Authors:  Andrew J Yates; Minus Van Baalen; Rustom Antia
Journal:  PLoS Comput Biol       Date:  2011-11-17       Impact factor: 4.475

4.  Agent-based modeling of the immune system: NetLogo, a promising framework.

Authors:  Ferdinando Chiacchio; Marzio Pennisi; Giulia Russo; Santo Motta; Francesco Pappalardo
Journal:  Biomed Res Int       Date:  2014-04-22       Impact factor: 3.411

Review 5.  Endothelial Dysfunction through Oxidatively Generated Epigenetic Mark in Respiratory Viral Infections.

Authors:  Spiros Vlahopoulos; Ke Wang; Yaoyao Xue; Xu Zheng; Istvan Boldogh; Lang Pan
Journal:  Cells       Date:  2021-11-07       Impact factor: 6.600

6.  Plasticity in transmission strategies of the malaria parasite, Plasmodium chabaudi: environmental and genetic effects.

Authors:  Angus Cameron; Sarah E Reece; Damien R Drew; Daniel T Haydon; Andrew J Yates
Journal:  Evol Appl       Date:  2012-10-10       Impact factor: 5.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.